期刊文献+

多发性骨髓瘤抗原致敏树突状细胞介导的体外抗瘤活性

Specific cell immune response mediated by dendritic cells in multiple myeloma patients in vitro
下载PDF
导出
摘要 目的:探讨多发性骨髓瘤KM 3细胞株冻融抗原和弱酸洗脱抗原肽负载树突状细胞(DC)后诱导的特异性细胞毒性T淋巴细胞(CTL)对KM 3细胞的杀瘤作用。方法:联合GM-CSF,IL-4和TNF-α,体外诱导单核细胞生成DC,并使其致敏KM 3特异性冻融抗原或酸洗脱抗原,然后与自体T淋巴细胞共同培养3 d,生成特异性CTL,并采用MTT法检测其对KM 3细胞的杀伤率。结果:在细胞因子作用下,体外培养的外周血单个核细胞可诱导分化为成熟的DC;应用KM 3肿瘤抗原致敏DC,诱导生成的CTL对KM 3肿瘤细胞具有较强的杀伤效应。结论:KM 3冻融抗原和酸洗脱抗原激发的DC与自体T淋巴细胞孵育能诱生抗KM 3细胞特异性CTL。 Objective To explore KM3 multiple myeloma (MM) cell line specific cytotoxic T lymphocyte (CTL) response in vitro mediated by autologous dendritic cells ( DCs ) aroused by KM3 cells' lysates and acid-eluted peptides. Methods Monocytes were isolated from the peripheral blood of healthy individuals and MM patients, and were cultured in serum medium with IL-4, GM-CSF, and TNF-α to generate DCs. These DCs were pulsed by KM3 cells' lysates or the acid-eluted pep- tides, then incubated with autologous T lymphocytes for 3 days to induce KM3 cell antigen specific CTL. MTT assay was performed to examine the specific KM 3 cells' lysing ability of CTL. Results DCs were generated in peripheral blood monocytes cultured in the serum medium containing GM-CSF, IL-4, and TNF-ct. Autologous T lymphocytes induced by IL-2 and DCs pulsed with KM3 cells' lysates or the acid-eluted peptides showed strong killing effect on KM3 cells. Conclusion The DCs pulsed by KM3 cells' lysates or the acid-eluted peptides incubated with autologous T lymphocytes can induce KM3 cell antigen specific CTL.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2006年第2期222-227,共6页 Journal of Central South University :Medical Science
基金 湖南省卫生厅科研基金(Y-03-060)
关键词 多发性骨髓瘤 树突状细胞 免疫治疗 冻融抗原肽 酸洗脱抗原肽 multiple myeloma dendritic cell immune therapy cell lysates acideluted peptides
  • 相关文献

参考文献21

  • 1陈慰峰.医学免疫学[M](第3版)[M].北京:人民卫生出版社,2001.136.
  • 2Sandberg JK,Grufman P,Wolpert EZ,et al.Superdominance among immunodominant H-2K(b)-restricted epitopes and reversal by dendritic cell-mediated antigen delivery[J].J Immunol,1998,160(5):3163-3169.
  • 3Menetrier C,Montmain G,Dieu MC,et al.Inhibition of the differentiation of dendritic cells from CD34+ progenitors by tumor cells:Role of interleukin-6 and macrophage colony-stimulating factor[J].Blood,1998,92(15):4778-4791.
  • 4Fong L.Dendritic cells in cancer immunotherapy[J].Annu Rev Immunol,2000,18(12):245-273.
  • 5Santini SM,Belardelli F.Advances in the use of dendritic cells and new adjuvants for the development of therapeutic vaccines[J].Stem Cells,2003,21(4):495-505.
  • 6Lipscomb MF,Masten BJ.Dendritic cells:immune regulators in health and disease[J].Physiol Rev,2002,82(1):97-130.
  • 7董炜疆,胡海涛,宫惠琳.多抗甲素与GM-CSF,TNF-α,IL-4联用对脐血单个核细胞抑瘤效应[J].中南大学学报(医学版),2005,30(5):553-557. 被引量:9
  • 8Ferlozzeo G,Lein J,Paliard X,et al.Dentritic cells generated from CD34+ progenitor cells with flt-3 ligand,C-kit ligand,GM-CSF,IL-4 and TNF-α are functional antigen-prosenting cells resembling mature monocyte derived dentritic cells[J].J Immunother,2000,23(1):48-58.
  • 9刘薇,李传昶,卢光琇.粒-巨噬细胞集落刺激因子对小鼠体内树突状细胞增殖和活化的影响[J].中南大学学报(医学版),2006,31(1):32-35. 被引量:2
  • 10Marten A,Flieger D,Renoth S,et al.Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells:Pre-clinical results and outcome of a first clinical phase I/II trial[J].Cancer Immunol,2002,51(11):637-644.

二级参考文献34

  • 1Steinman RM.The dendritic cell system and its role in immunogenicity[J].Annu Rev Immunol,1991,9(1):271-296.
  • 2Banchereau J,Steinman RM.Dendritic cells and the control of immunity[J].Nature,1998,392(6673):245-252.
  • 3Fong L,Brockstedt D,Benike C,et al.Dendritic cells injected via different routes induce immunity in cancer patients[J].J Immunol,2001,166(6):4254-4259.
  • 4Su Z,Dannull J,Heiser A,et al.Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-tranferected dendritic cells[J].Cancer Res,2003,63(9):2127-2133.
  • 5Guillot C,Menoret S,Guillonneau C,et al.Active suppression of allogeneic proliferation responses by dendritic cells after induction of long-term allograft survival by CTL 4Ig[J].Blood,2003,101(8):3325-3328.
  • 6Vremec D,Shortman K.Dendritic cell subtypes in mouse lym-phoid organ:cross-correlation of surface markers,changes with incubation,and difference among thymus,spleen and lymph nodes[J].J Immunol,1997,159(2):565-573.
  • 7Yao V,Platell C,Hall JC.Dendritic cells[J].Annu Surg,2002,672(7):501-506.
  • 8Alters SE,Gadea JR,Holm B,et al.IL-13 can substitute for IL-4 in the generation of dendritic cells for the induction of cytotoxic T lymphocytes and gene therapy[J].J Immunother,1999,22(3):229-236.
  • 9Ferlazzo G,Klein J,Paliard X,et al.Dendritic cells generated from CD34+ progeniter cells with flt3 ligand,c-kit ligand,GM-CSF,IL-4,and TNF-α are functional antigen-presenting cells resembling mature monocyte-derived dendritic cells[J].J Immunother,2000,23(1):48-58.
  • 10Basak SK,Harui A,Stolina M,et al.Increased dendritic cell number and function following continuous in vivo infusion of granulocyte macrophage-colony-stimulating factor and interleukin-4[J].Blood,2002,99(8):2869-2879.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部